Patents Assigned to Lucigen Corporation
  • Patent number: 10093918
    Abstract: Devices and methods for collecting, processing, and analyzing a sample. A sample collection module is configured for collecting, mixing diluting, and filtering a sample for analysis. A reaction cartridge is configured for processing a sample, mixing it with dried reagents, and conducting a chemical reaction for detecting target analytes.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: October 9, 2018
    Assignee: LUCIGEN CORPORATION
    Inventors: Cindy Mielke, Kyle Williamson, James Koelbl, Dylann Ceriani, Chris da Costa, Espir Kahatt
  • Patent number: 9765343
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: September 19, 2017
    Assignee: LUCIGEN CORPORATION
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • Publication number: 20160348189
    Abstract: Methods of detecting RNA, such as ribosomal RNA (rRNA), messenger RNA (mRNA), and others. The methods include heating a cell comprising RNA in a solution to release the RNA from the cell, reverse transcribing the RNA into DNA with an enzyme, amplifying the DNA with the same enzyme, and detecting the amplified DNA. The heating, reverse-transcribing, and amplifying in at least some of the methods are performed at substantially the same temperature and a substantially constant temperature without adding additional reagents during or between the steps. The methods can be used to detect the presence of one cell type as distinguished from another cell type within a sample or to determine levels of gene expression, each without the need for elaborate extraction protocols.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Applicant: LUCIGEN CORPORATION
    Inventor: Thomas William Schoenfeld
  • Publication number: 20160229899
    Abstract: Described herein are isolated polynucleotides that encode a fluorescent protein which is at least 80% sequence identical to a protein selected from the group consisting of SEQ. ID. NOS: 2, 4, 6, 10, 14, 18, 22, 26, 30, 34, 38, 42, 46, 50, 54, 58, 62, 66, 70, and 74. Also described are expression constructs containing the polynucleotides, transformed host cells containing the expression constructions, the encoded fluorescent proteins themselves, and methods of using the nucleotides and encoded fluorescent proteins for bioanalytical research.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 11, 2016
    Applicant: Lucigen Corporation
    Inventors: Michele E. Auldridge, Laura P. Franz, David Mead, Saurabh Sen, Eric J. Steinmetz
  • Patent number: 9354175
    Abstract: Described herein are isolated polynucleotides that encode a fluorescent protein which is at least 80% sequence identical to a protein selected from the group consisting of SEQ. ID. NOS: 2, 4, 6, 10, 14, 18, 22, 26, 30, 34, 38, 42, 46, 50, 54, 58, 62, 66, 70, and 74. Also described are expression constructs containing the polynucleotides, transformed host cells containing the expression constructions, the encoded fluorescent proteins themselves, and methods of using the nucleotides and encoded fluorescent proteins for bioanalytical research.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: May 31, 2016
    Assignee: Lucigen Corporation
    Inventors: Michele E. Auldridge, Laura P. Franz, David Mead, Saurabh Sen, Eric J. Steinmetz
  • Publication number: 20150353919
    Abstract: Devices and methods for collecting, processing, and analyzing a sample. A sample collection module is configured for collecting, mixing diluting, and filtering a sample for analysis. A reaction cartridge is configured for processing a sample, mixing it with dried reagents, and conducting a chemical reaction for detecting target analytes.
    Type: Application
    Filed: June 3, 2015
    Publication date: December 10, 2015
    Applicant: Lucigen Corporation
    Inventors: Cindy Mielke, Kyle Williamson, James Koelbl, Dylann Ceriani, Chris da Costa, Espir Kahatt
  • Publication number: 20150218565
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 6, 2015
    Applicant: Lucigen Corporation
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • Publication number: 20150198533
    Abstract: Described herein are isolated polynucleotides that encode a fluorescent protein which is at least 80% sequence identical to a protein selected from the group consisting of SEQ. ID. NOS: 2, 4, 6, 10, 14, 18, 22, 26, 30, 34, 38, 42, 46, 50, 54, 58, 62, 66, 70, and 74. Also described are expression constructs containing the polynucleotides, transformed host cells containing the expression constructions, the encoded fluorescent proteins themselves, and methods of using the nucleotides and encoded fluorescent proteins for bioanalytical research.
    Type: Application
    Filed: January 10, 2014
    Publication date: July 16, 2015
    Applicant: LUCIGEN CORPORATION
    Inventors: MICHELE E. AULDRIDGE, LAURA P. FRANZ, DAVID MEAD, SAURABH SEN, ERIC J. STEINMETZ
  • Patent number: 9029134
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: May 12, 2015
    Assignee: Lucigen Corporation
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • Patent number: 8623652
    Abstract: A system for ligase-free cloning and/or expressing a target gene is described herein. A preferred version of the invention includes an E. coli host. The host preferably includes a T7 RNA polymerase gene comprising a T7gpl coding sequence, a lacUV5 promoter, and a lac operator. The host preferably further includes a lacI gene comprising a lacI coding sequence with an ATG start codon, a promoter derived from the lacql allele, and a translational enhancer derived from a 5? RNA leader sequence of T7 gene 10. The invention further includes a low-copy plasmid vector comprising a T7 promoter a lac operator operationally linked to the T7 promoter. The system is configured to inhibit target gene expression when uninduced and to permit gene expression upon induction by auto-induction.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: January 7, 2014
    Assignee: Lucigen Corporation
    Inventors: Eric Steinmetz, Ronald Godiska, David A. Mead
  • Patent number: 8093030
    Abstract: Thermostable viral polymerases exhibiting a combination of activities selected from, proofreading (3?-5?) exonuclease activity, nick translating (5?-3?) nuclease activity, synthetic primer-initiated polymerase activity, nick-initiated polymerase activity, reverse transcriptase activity, strand displacement activity, and/or decreased discrimination against incorporation of nucleotide analogs. Also provided are compositions including the polymerases, polynucleotides encoding the polymerases and methods of using the polymerases.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: January 10, 2012
    Assignee: Lucigen Corporation
    Inventors: Thomas W. Schoenfeld, Vinay K. Dhodda, Robert A. Difrancesco, David A. Mead
  • Patent number: 7723103
    Abstract: Vector preparations and cloning constructs suitable for use in cloning are provided. Vector preparations are double-stranded DNA molecules having two 3? termini, each terminus having a single base pair overhang that is capable of hybridizing to a single base pair overhang on a double stranded polynucleotide sequence to be cloned. The overhang of the vector preparation is suitably a dCMP and the overhang of the polynucleotide sequence to be cloned is suitably a dGMP. In other embodiments, the overhang of the polynucleotide sequence to be cloned is any ddNTP and the corresponding overhang of the vector preparation is any base that pairs to the ddNTP. The latter embodiment is particularly suited to preparing recombinant molecules having only a single insert. Methods of cloning, methods of preparing libraries of recombinant molecules and kits for carrying out the methods are also provided.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: May 25, 2010
    Assignee: Lucigen Corporation
    Inventors: David A. Mead, Ronald Godiska, Thomas W. Schoenfeld, Spencer Hermanson
  • Publication number: 20090263873
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Application
    Filed: January 12, 2007
    Publication date: October 22, 2009
    Applicant: LUCIGEN CORPORATION
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • Publication number: 20080268498
    Abstract: Thermostable viral polymerases exhibiting a combination of activities selected from, proofreading (3?-5?) exonuclease activity, nick translating (5?-3?) nuclease activity, synthetic primer-initiated polymerase activity, nick-initiated polymerase activity, reverse transcriptase activity, strand displacement activity, and/or decreased discrimination against incorporation of nucleotide analogs. Also provided are compositions including the polymerases, polynucleotides encoding the polymerases and methods of using the polymerases.
    Type: Application
    Filed: October 6, 2006
    Publication date: October 30, 2008
    Applicant: LUCIGEN CORPORATION
    Inventors: Thomas W. Schoenfeld, Vinay K. Dhodda, Robert A. Difrancesco, David A. Mead
  • Publication number: 20080166773
    Abstract: Vector preparations and cloning constructs suitable for use in cloning are provided. Vector preparations are double-stranded DNA molecules having two 3? termini, each terminus having a single base pair overhang that is capable of hybridizing to a single base pair overhang on a double stranded polynucleotide sequence to be cloned. The overhang of the vector preparation is suitably a dCMP and the overhang of the polynucleotide sequence to be cloned is suitably a dGMP. In other embodiments, the overhang of the polynucleotide sequence to be cloned is any ddNTP and the corresponding overhang of the vector preparation is any base that pairs to the ddNTP. The latter embodiment is particularly suited to preparing recombinant molecules having only a single insert. Methods of cloning, methods of preparing libraries of recombinant molecules and kits for carrying out the methods are also provided.
    Type: Application
    Filed: January 8, 2007
    Publication date: July 10, 2008
    Applicant: LUCIGEN CORPORATION
    Inventors: David A. Mead, Ronald Godiska, Thomas W. Schoenfeld, Spencer Hermanson
  • Publication number: 20050282155
    Abstract: Provided is a method for producing viral genomic and complementary DNA expression libraries and novel viral polypeptides without requiring virus cultivation prior to library construction. The method includes direct isolation of viral particles from the environment by differential filtration and centrifugation. The viral nucleic acids are extracted and used to construct libraries that may be screened by one of several methods to identify useful coding sequences or may be used to produce novel polypeptides.
    Type: Application
    Filed: June 15, 2005
    Publication date: December 22, 2005
    Applicant: Lucigen Corporation
    Inventors: Thomas Schoenfeld, David Mead
  • Publication number: 20040038401
    Abstract: The present invention relates to systems, methods, and compositions for cloning and sequencing insert nucleic acid sequences. In particular, the present invention provides vectors and vector components configured for multiplex cloning, multiplex sequencing, and fixed orientation cloning. The present invention also provides vectors and vector components that allow insert sequences that are deleterious to a host cell to be successfully cloned.
    Type: Application
    Filed: November 15, 2001
    Publication date: February 26, 2004
    Applicant: Lucigen Corporation
    Inventors: David Alan Mead, Ronald Godiska